GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (CHIX:BIONz) » Definitions » Cyclically Adjusted Book per Share

BB Biotech AG (CHIX:BIONZ) Cyclically Adjusted Book per Share : CHF54.40 (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is BB Biotech AG Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BB Biotech AG's adjusted book value per share for the three months ended in Sep. 2024 was CHF40.655. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is CHF54.40 for the trailing ten years ended in Sep. 2024.

During the past 12 months, BB Biotech AG's average Cyclically Adjusted Book Growth Rate was 6.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BB Biotech AG was 6.30% per year. The lowest was 3.10% per year. And the median was 4.35% per year.

As of today (2025-05-31), BB Biotech AG's current stock price is CHF35.95. BB Biotech AG's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was CHF54.40. BB Biotech AG's Cyclically Adjusted PB Ratio of today is 0.66.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BB Biotech AG was 1.27. The lowest was 0.43. And the median was 1.14.


BB Biotech AG Cyclically Adjusted Book per Share Historical Data

The historical data trend for BB Biotech AG's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Cyclically Adjusted Book per Share Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.25 39.36 78.22 45.51 37.39

BB Biotech AG Quarterly Data
Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.91 37.39 41.08 37.07 54.40

Competitive Comparison of BB Biotech AG's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, BB Biotech AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Cyclically Adjusted PB Ratio falls into.


;
;

BB Biotech AG Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BB Biotech AG's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book= Book Value per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=40.655/107.4679*107.4679
=40.655

Current CPI (Sep. 2024) = 107.4679.

BB Biotech AG Quarterly Data

Book Value per Share CPI Adj_Book
201203 75.624 101.826 79.814
201206 84.026 101.596 88.882
201209 121.527 101.392 128.810
201212 108.637 100.968 115.631
201303 118.392 101.221 125.698
201306 141.792 101.466 150.179
201309 28.611 101.336 30.342
201312 31.052 101.036 33.029
201403 30.790 101.224 32.689
201406 33.666 101.517 35.640
201409 40.809 101.247 43.317
201412 61.909 100.704 66.067
201503 65.823 100.339 70.500
201506 71.975 100.464 76.993
201509 62.252 99.785 67.045
201512 71.429 99.386 77.237
201603 46.900 99.475 50.668
201606 47.550 100.088 51.056
201609 54.668 99.604 58.984
201612 54.222 99.380 58.635
201703 58.251 100.040 62.576
201706 60.091 100.285 64.395
201712 63.875 100.213 68.499
201812 52.067 100.906 55.453
201912 61.245 101.063 65.126
202012 70.172 100.241 75.231
202103 0.000 100.800 0.000
202106 0.000 101.352 0.000
202112 59.384 101.776 62.705
202203 50.081 103.205 52.150
202206 45.821 104.783 46.995
202209 0.000 104.835 0.000
202212 48.976 104.666 50.287
202303 41.497 106.245 41.975
202306 41.252 106.576 41.597
202309 40.369 106.570 40.709
202312 42.359 106.461 42.760
202403 45.108 107.355 45.155
202406 43.521 107.991 43.310
202409 40.655 107.468 40.655

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


BB Biotech AG  (CHIX:BIONz) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BB Biotech AG's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=35.95/54.40
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BB Biotech AG was 1.27. The lowest was 0.43. And the median was 1.14.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BB Biotech AG Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG Business Description

Industry
Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.

BB Biotech AG Headlines

No Headlines